胸廓内动脉是否抵抗再灌注损伤?游离胸廓内动脉移植物保存的评估
研究在猪模型中比较游离与在位胸廓内动脉(ITA)移植后的内皮功能,游离ITA分别保存于生理盐水、Custodiol和Tiprotec溶液。再灌注2小时后,游离ITA组内皮功能与完整性严重受损,Tiprotec组部分保留;在位ITA未见损伤迹象。作者认为Tiprotec可能是冠状动脉旁路移植术中游离动脉移植物保存的可行选择。
要点
- 游离ITA再灌注后内皮功能与完整性严重受损,在位ITA未见损伤迹象。
- Tiprotec保存的游离ITA内皮功能部分保留。
- 游离ITA组再灌注后硝化氧化应激、DNA断裂及血管细胞黏附蛋白1等评分升高,内皮型一氧化氮合酶评分降低。
核心结论
- 游离ITA保存后再灌注可导致早期严重内皮功能障碍,而在位ITA移植可完全预防此种损伤。
- Tiprotec可能是冠状动脉旁路移植术中游离动脉移植物保存的可行选择。
研究设计与样本
- 猪模型实验,ITA分别作为游离或在位移植物获取,游离移植物保存于生理盐水、Custodiol和Tiprotec溶液,非体外循环吻合至左前降支,再灌注2小时后获取移植物评估内皮功能、组织病理学和基因表达,新鲜获取的ITA作为对照。
主要发现
- 再灌注后游离ITA组内皮功能与完整性严重受损,Tiprotec组部分保留。
- 游离ITA组再灌注损伤导致硝化氧化应激、DNA断裂、血管细胞黏附蛋白1、细胞间黏附分子-1和caspase-3评分升高,内皮型一氧化氮合酶评分降低。
- 在位ITA移植物未见损伤迹象。
- 各组间mRNA水平显著改变。
临床怎么用
- 作者认为Tiprotec可能是冠状动脉旁路移植术中游离动脉移植物保存的可行选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The in situ internal thoracic artery (ITA) is recognized as the best conduit for coronary artery bypass surgery. The ITA-if it is used as an in situ graft-has a much higher late patency rate than any other arterial graft, including a free ITA graft. We sought to determine if the use of the ITA as an in situ/free graft and its storage in preservation solutions, have an effect on endothelial function. METHODS: The ITA was harvested as either a free or in situ graft in a porcine model. Free grafts were stored in different preservation solutions (saline, Custodiol and Tiprotec [both Köhler Chemie GmbH, Bensheim, Germany]). The ITA was anastomosed off pump to the left anterior descending artery (as in situ/free graft). Freshly harvested ITA served as a control. After 2 hours of reperfusion, the implanted grafts were harvested. The assessment of endothelial function, histopathological analysis, and gene expression were performed. RESULTS: Endothelial function and integrity were severely impaired after reperfusion in the free ITA groups, however, it was partially preserved in the Tiprotec group. Reperfusion injury resulted in increased nitro-oxidative stress, DNA breakage, vascular cell adhesion protein 1, intercellular adhesion molecule-1, and caspase-3 scores, and a decreased endothelial nitric oxide synthase score in the free ITA groups. The in situ ITA graft showed no signs of injury. mRNA levels were significantly altered among the groups. CONCLUSIONS: An early, severe endothelial dysfunction of the stored, free ITA as described, could be completely prevented by the use of an in situ ITA graft. Tiprotec might be a feasible option for storage of free arterial grafts during coronary artery bypass grafting.
引用
- Veres G, Schmidt H, Hegedűs P, et al. Is internal thoracic artery resistant to reperfusion injury? Evaluation of the storage of free internal thoracic artery grafts. J Thorac Cardiovasc Surg. 2018. PMID: 30257283. doi:10.1016/j.jtcvs.2018.05.079
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。